REQUEST A DEMO
Total
USD $0.00
Search more companies

JW Cayman Therapeutics Company Limited (China)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: JW Cayman Therapeutics Company Limited Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

JW Cayman Therapeutics Company Limited is a high-tech enterprise located in Hong Kong. The company specializes in the manufacturing of high-end integrated optical, mechanical, and electrical instruments. They provide process design, equipment manufacturing, and testing and validation system solutions for biopharmaceutical engineering. Additionally, they offer medical equipment and specialized services for the medical and disease control fields. JW Cayman Therapeutics also provides precision testing and analysis instruments for research, teaching, environmental, electronic, and electrical industries. The company was founded in 1993 with a focus on innovation and has positioned innovation as its core competitive advantage. They prioritize proactive research on industry development trends, enabling them to seize opportunities and quickly enter the market. JW Cayman Therapeutics follows a philosophy of prudent and steady development, maintaining consistency in strategic goals, leadership stability, and professional business operations. They aim to become a distinctive and specialized enterprise.

Headquarters
4F, Building 42, No. 225 Meisheng Road, Pilot Free Trade Zone, Prc
Shanghai; Shanghai;

Contact Details: Purchase the JW Cayman Therapeutics Company Limited report to view the information.

Website: http://www.jwtherapeutics.com

Basic Information
Total Employees:
Purchase the JW Cayman Therapeutics Company Limited report to view the information.
Outstanding Shares:
Purchase the JW Cayman Therapeutics Company Limited report to view the information.
Registered Capital:
Purchase the JW Cayman Therapeutics Company Limited report to view the information.
Financial Auditors:
Purchase the JW Cayman Therapeutics Company Limited report to view the information.
Incorporation Date:
September 06, 2017
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Chief Technology Officer
Purchase this report to view the information.
Senior Vice President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
17.52%
Purchase this report to view the information.
12.1%
Purchase this report to view the information.
9.54%
Purchase this report to view the information.
5.65%
Purchase this report to view the information.
5.44%
Subsidiaries
Aeon Therapeutics (Beijing) Limited
100%
Eureka (Beijing) Biotechnology Co., Ltd
100%
Jw (Hong Kong) Therapeutics Limited (Hong Kong SAR, China)
100%
Company Performance
Financial values in the chart are available after JW Cayman Therapeutics Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
19.32%
Total operating revenue
24.98%
Operating profit (EBIT)
10.35%
EBITDA
37.33%
Net Profit (Loss) for the Period
9.23%
Total assets
-23.12%
Total equity
-28.48%
Operating Profit Margin (ROS)
143.26%
Net Profit Margin
138.99%
Return on Equity (ROE)
-9.67%
Debt to Equity Ratio
7.07%
Quick Ratio
-0.74%
Cash Ratio
-0.65%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?